Basel, Switzerland, 22 April 2015 - Visitors attending Vitafoods Europe 2015, Geneva, Switzerland, 5-7 May 2015, can expect to hear plenty of buzz at the Lonza Consumer Care Booth, # K36.
In 2015 Lonza is celebrating its 30th Anniversary of manufacturing and marketing the Carnipure® ingredient, a premium grade of L-Carnitine. At Vitafoods Europe, Lonza will be presenting how 30 years of building science and applications provides a solid base for future innovation and growth of the ingredient.
Lonza, with OrganoBalance, will also be presenting "A New Ingredient for Helicobacter pylori Control" on the main conference program.
In addition, as part of its new "World of Care" initiative, Lonza Consumer Care will make a charitable donation to Vitamin Angels. Exhibitors and attendees who visit Lonza Booth # K36 at Vitafoods 2015 will be invited to place a magnet on Lonza’s "World of Care" map and a donation will be made by Lonza on their behalf to Vitamin Angels. Vitamin Angels helps at-risk populations in need – specifically pregnant women, new mothers and children under five – gain access to lifesaving and life-changing vitamins and minerals. www.vitaminangels.org.
Lonza Presentations at Vitafoods Europe 2015:
- 30 years of Carnipure® and nowhere near commodity
- Key drivers for continuous growth rates
- Lessons learned from the success model and what’s next
Time: Tuesday, 5 May 2015, 15:10 - 15:40
Location: Exhibitor Presentation Theatre
Speaker: Ulla Freitas, Scientific Marketing Director, Nutrition, Lonza Ltd
"
"A New Ingredient for Helicobacter pylori Control"
- Alternatives to antibiotic therapy for Helicobacter pylori management
- Analysis of non-viable Lactobacillus reuteri DSM 17648 in Helicobacter pylori control
- Results of two human studies applying non-viable Lactobacillus reuteri DSM 17648 to asymptomatic subjects
Time: Tuesday, 5 May 2015, 11:40-12:00
Location: Main Conference Program: Stream 2: Your Science > Digestive Health
Speakers: Ulla Freitas, Scientific Marketing Director, Nutrition, Lonza Ltd and Dr. Klaus Pellengahr, Director Business Development, OrganoBalance GmbH